Companies: 10,795·Total market cap: $144.5T
Century Therapeutics, Inc.

Century Therapeutics, Inc.

IPSCNASDAQHealthcare● Active
$2.12
$-0.01(-0.47%)
Market Cap$183527105
P/E Ratio
52W High$3.04
52W Low$0.435
Overview

Century Therapeutics, Inc. (IPSC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · IPSC · as of Mar 12, 2026

Latest filing snapshot

78
-62-44.29%vs prior year

Century Therapeutics, Inc. (IPSC) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
78
Change (1Y)
-62
Growth % (1Y)
-44.29%
Revenue / Employee
$1.40M
Net Income / Employee
$-122.8K
Market Cap
$184M

IPSC Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1278-62-44.29%
2025-03-19140-25-15.15%
2024-03-14165-19-10.33%
2023-03-16184-4-2.13%
2022-03-17188

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Karyopharm Therapeutics Inc.
KPTI
Karyopharm Therapeutics Inc.
279
#2
Century Therapeutics, Inc.
IPSC
Century Therapeutics, Inc.YOU
78
#3
Cue Biopharma, Inc.
CUE
Cue Biopharma, Inc.
41
#4
Equillium, Inc.
EQ
Equillium, Inc.
35
#5
Genenta Science S.p.A.
GNTA
Genenta Science S.p.A.
13
#6
Medicus Pharma Ltd. Common Stock
MDCX
Medicus Pharma Ltd. Common Stock
12
#7
Coeptis Therapeutics, Inc.
COEP
Coeptis Therapeutics, Inc.
5
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · IPSC peer comparison

About IPSC employees

IPSC Employees · Headcount

Century Therapeutics, Inc. (IPSC) employee data is sourced from the annual SEC 10-K filing. As of 2025, Century Therapeutics, Inc. had 78 full-time employees globally. Full-time employees only. Global consolidated headcount.

Century Therapeutics, Inc. employs 78 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.40M, reflecting the company's operational efficiency.

Century Therapeutics, Inc.'s workforce decreased by 62 (44.29%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Century Therapeutics, Inc.'s revenue per employee of $1.40M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

IPSC Employees · 5 questions

As of the latest SEC 10-K filing (2025), Century Therapeutics, Inc. had 78 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Century Therapeutics, Inc. employee counthow many employees does Century Therapeutics, Inc. haveIPSC total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12